Evidence map›Paper›PMID 34447604›Full record

ArticleJournal of pathology informatics2021

Digital Pathology-based Study of Cell- and Tissue-level Morphologic Features in Serous Borderline Ovarian Tumor and High-grade Serous Ovarian Cancer.

Jun Jiang, Burak Tekin, Ruifeng Guo, Hongfang Liu, Yajue Huang, Chen Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of pathology informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Role of artificial intelligence in digital pathology for gynecological cancers.Computational and structural biotechnology journal · 2024
    Review
  5. Review
  6. Multiplex Immunofluorescence Image Quality Checking Using DAPI Channel-referenced Evaluation.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2023
    Article
  7. Article
  8. Computational pathology in ovarian cancer.Frontiers in oncology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jun JiangDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA.
Burak TekinDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Ruifeng GuoDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Hongfang LiuDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA.
Yajue HuangDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Chen WangDepartment of Health Science Research, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerous borderline ovarian tumor (SBOT) and high-grade serous ovarian cancer (HGSOC) are two distinct subtypes of epithelial ovarian tumors, with markedly different biologic background, behavior, prognosis, and treatment. However, the histologic diagnosis of serous ovarian tumors can be subjectively variable and labor-intensive as multiple tumor slides/blocks need to be thoroughly examined to search for these features. MATERIALS AND

methodsWe developed a novel informatics system to facilitate objective and scalable diagnosis screening for SBOT and HGSOC. The system was built upon Groovy scripts and QuPath to enable interactive annotation and data exchange.

resultsThe system was used to successfully detect cellular boundaries and extract an expanded set of cellular features representing cell- and tissue-level characteristics. The performance of cell-level classification for both tumor and stroma cells achieved >90% accuracy. The performance of differentiating HGSOC versus SBOT achieved 91%-95% accuracy for 6485 imaging patches which have sufficient tumor and stroma cells (minimum of ten each) and 97% accuracy for classifying patients when aggregating the results to whole-slide image based on consensus.

conclusionsCellular features digitally extracted from pathological images can be used for cell classification and SBOT v. HGSOC differentiation. Introducing digital pathology into ovarian cancer research could be beneficial to discover potential clinical implications. A larger cohort is required to further evaluate the system.

Indexed as

Digital pathologyhigh-grade serous ovarian cancerserous borderline ovarian tumor

Identifiers

PMID34447604
PMCPMC8356706
OpenAlexW3171501123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.